Search

Pharmaceutical Forms: 40 mg coated tablets x 28 units
30mg coated tablets x 28 units

Therapeutic Area: Oncology

Active Ingredient: Afatinib

Pharmaceutical Forms: 1 glass vial containing 440 mg of lyophilized powder Reconstituted solution 21mg/mL

Therapeutic Area: Oncology

Active Ingredient: Trastuzumab

Pharmaceutical Forms: 5 mg x 30 tablets
10 mg x 30 tablets

Therapeutic Area: Oncology

Active Ingredient: Everolimus

Pharmaceutical Forms: 125 mg capsules x 21
100 mg capsules x 21
75 mg capsules x 21

Therapeutic Area: Oncology

Active Ingredient: Palbociclib

Pharmaceutical Forms: 1 vial containing 0.44 mg/mL

Therapeutic Area: Antineoplastic + Oncology

Active Ingredient: Eribulin Mesylate

Pharmaceutical Forms: 12.5 mg x 28 capsules
25 mg x 28 capsules
50 mg x 28 capsules

Therapeutic Area: Oncology

Active Ingredient: Sunitinib

Pharmaceutical Forms: 40 mg x 120 hard capsules

Therapeutic Area: Oncology + Urologic Oncology

Active Ingredient: Enzalutamide

Pharmaceutical Forms: Solution 10 mg/ml.
1 vial x 50 ml (500 mg)
2 vials x 10ml (100 mg)

Therapeutic Area: Oncohematology + Oncology + Rheumatology

Active Ingredient: Rituximab

Pharmaceutical Forms: 1 ampoule bottle with 1 mg solution

Therapeutic Area: Oncology

Active Ingredient: Racotumomab

Pharmaceutical Forms: 20 mg trifluridine/8.19 mg tipiracil coated tablets x 20
20 mg trifluridine/8.19 mg tipiracil coated tablets x 60

Therapeutic Area: Oncology

Active Ingredient: Tipiracile + Trifluridine